Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS

YAN Lin; OU Zemin; WANG Yanjing; ZHANG Yao; CHENG Yi; WANG Zicheng; LIU Dewen; WANG Jinyu; MA Zhenshan; TONG Yan

doi:10.13422/j.cnki.syfjx.20230866

您当前的位置：

首页 >

文章列表页 >

Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS

更新时间：2023-11-07

- Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 23, Pages: 122-130(2023)
- 作者机构：
  
  1.江西中医药大学，南昌 330004
  2.中国中医科学院中药研究所，北京 100700
  3.天津中医药大学，天津 301617
  4.北京城市学院，北京 100083
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20230866
  CLC： R22;R943.1;R28;O657
- Received：23 February 2023，
  
  Published Online：28 April 2023，
  
  Published：05 December 2023
- 稿件说明：
移动端阅览
严林,欧则民,王艳静等.基于UPLC-Q-TOF-MS的泽泻盐制前后血清药物化学比较分析[J].中国实验方剂学杂志,2023,29(23):122-130.

YAN Lin,OU Zemin,WANG Yanjing,et al.Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(23):122-130.
严林,欧则民,王艳静等.基于UPLC-Q-TOF-MS的泽泻盐制前后血清药物化学比较分析[J].中国实验方剂学杂志,2023,29(23):122-130. DOI： 10.13422/j.cnki.syfjx.20230866.

YAN Lin,OU Zemin,WANG Yanjing,et al.Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(23):122-130. DOI： 10.13422/j.cnki.syfjx.20230866.

摘要

目的

基于超高效液相色谱-四极杆-飞行时间质谱法（UPLC-Q-TOF-MS）对泽泻、盐泽泻水提液灌胃给药后大鼠血清中的移行成分进行比较分析。

方法

SD大鼠随机分为空白组、泽泻组（10 g·kg

-1

）和盐泽泻组（10 g·kg

-1

），每组3只，给药组分别灌胃给予泽泻、盐泽泻水提液，空白组灌胃等体积饮用水，早晚各1次，连续3 d，末次给药60 min后，眼眶采血，制备血清样品。采用ACQUITY UPLC BEH C

（2.1 mm×50 mm，1.7 μm）色谱柱，流动相乙腈（A）-0.1%甲酸水溶液（B），梯度洗脱（0~10 min，10%~50% A；10~27 min，50%~95% A；27~27.1 min，95%~10% A；27.1~30 min，10% A），流速0.3 mL·min

-1

，正离子模式下采集数据，扫描范围

100~1 200。在自建泽泻化学成分库的基础上借助UNIFI 1.9.2软件对泽泻、盐泽泻水提液及给药血清、空白血清的总离子流图和二级质谱碎片信息进行比对，推导泽泻、盐泽泻可能的入血移行成分及其裂解规律，并计算各化学成分炮制前后的响应强度比。

结果

在给予泽泻水提液大鼠血清中分析推测得到20个成分，包括5个原型成分和15个代谢产物；在给予盐泽泻水提液大鼠血清中分析推测得到14个成分，包括5个原型成分和9个代谢成分；其中两者共有成分13个，包括5个原型成分和8个代谢成分。5个原型成分分别为16-氧代泽泻醇A、24-乙酰泽泻醇A、泽泻醇A、泽泻醇B、泽泻醇C，代谢产物主要涉及Ⅰ相代谢（氧化反应）和Ⅱ相代谢（葡萄糖醛酸化反应）；盐泽泻组大鼠血清中原型成分16-氧代泽泻醇A、泽泻醇B、泽泻醇C的响应强度升高，而代谢成分种类及响应强度则普遍降低。

结论

泽泻盐制后可能通过减缓萜类成分代谢速率从而促进原型成分吸收入血，可为泽泻、盐泽泻的药效物质基础研究提供了数据支撑。

Abstract

Objective

Based on serum pharmacochemistry and ultra performance liquid chromatography-quadrupole-time-of-flight mass spectrometry（UPLC-Q-TOF-MS） the transitional components in the serum of rats after intragastric administration of water extract of Alismatis Rhizoma（AR）and salt-processed Alismatis Rhizoma（SAR） were compared.

Method

SD rats were randomly divided into blank group

AR group（10 g·kg

-1

） and SAR group（10 g·kg

-1

）

3 rats in each group

the administration groups were given AR and SAR aqueous extracts by gavage

respectively

and the blank group was given an equal volume of drinking water by gavage once in the morning and once in the evening

for 3 consecutive days. Sixty minutes after the last administration

blood was collected from the eye orbits

and the serum samples were prepared. The serum samples were prepared on an ACQUITY UPLC BEH C18 column（2.1 mm×50 mm

1.7 μm） with the mobile phase of acetonitrile（A）-0.1% formic acid aqueous solution（B） in a gradient elution（0-10 min

10%-50% A; 10-27 min

50%-95%A; 27-27.1 min

95%-10% A; 27.1-30 min

10%A）

the data were collected at a flow rate of 0.3 mL·min

-1

in positive ion mode with a scanning range of

100-1 200. Based on the self-constructed chemical composition library of AR

the total ion flow diagrams and secondary MS fragmentation information of the aqueous extracts of AR and SAR

as well as the administered serum and the blank serum

were compared with each other by UNIFI 1.9.2

so as to deduce the possible blood-migrating constituents and their cleavage patterns in the aqueous extracts

and the response intensity ratios of each chemical component were calculated before and after processing.

Result

A total of 20 components

including 5 prototypical components and 15 metabolites

were analyzed and deduced from the serum of rats given aqueous extract of AR. And 14 components

including 5 prototypical components and 9 metabolites

were analyzed and deduced from the serum of rats given aqueous extract of SAR. Of these

13 components were common to both of them

including 5 prototypical components and 8 metabolites. The 5 prototypical components were 16-oxoalisol A

alisol A 24-acetate

alisol A

alisol B and alisol C. The metabolites were mainly involved in phase Ⅰ metabolism（oxidation） and phase Ⅱ metabolism（glucuronidation）. There was a big change in the intensity of response of the common components before and after salt-processing

and the response intensities of the prototypical components

16-oxoalisol A

alisol B and alisol C

were elevated

while the type and response intensity of metabolites were generally decreased

and it was hypothesized that the metabolic rate of terpenoids might be slowed down after salt-processing of AR

so that the blood-migrating constituents could participate in the metabolism of the body more in the form of prototypes.

Conclusion

Salt-processing of AR may promote the absorption of prototypical components into the blood by slowing down the metabolic rate of terpenoids

which can provide support for the research on material basis of AR and SAR.

关键词

Keywords

references

国家药典委员会 . 中华人民共和国药典：一部［M］. 北京：中国医药科技出版社， 2020 ： 239 - 240 .

顾云龙，李兆健 . 泽泻功用的本草考证及现代研究进展［J］. 中医药导报， 2021 ， 27 （ 11 ）： 137 - 141 .

吴珍 . 23-乙酰泽泻醇B对肥胖模型小鼠糖脂代谢紊乱及肠道菌群的研究［D］. 广州：广东药科大学， 2022 .

徐小妹，李丽莎，张亚敏，等 . 基于转录组学技术研究泽泻汤对高脂血症大鼠的降脂作用机制［J］. 中国药学：英文版， 2021 ， 30 （ 5 ）： 409 - 420 .

伍小燕，陈朝，张国伟 . 泽泻水提物对正常大鼠利尿活性及肾脏髓质AQP2作用研究［J］. 实用临床医药杂志， 2010 ， 14 （ 21 ）： 5 - 7，10 .

黄小强，李宣宣，吴水生，等 . 泽泻三萜对小鼠急性肺损伤的保护作用［J］. 中成药， 2022 ， 44 （ 9 ）： 2979 - 2984 .

严林，李新健，张冰冰，等 . 泽泻汤的研究现状［J］. 中国实验方剂学杂志， 2021 ， 27 （ 16 ）： 191 - 197 .

毕丽伟，庞海月，陈煜沛，等 . 三种泽泻提取物的抗氧化活性及23-乙酰泽泻醇B含量的研究［J］. 化学与生物工程， 2021 ， 38 （ 1 ）： 34 - 37 .

陈中文 . 不同产地泽泻盐炙前后水提液中成分及其利尿作用分析［J］. 北方药学， 2016 ， 13 （ 9 ）： 126 - 127 .

严桂杰，蓝梦柳，丘建芳，等 . 泽泻炮制前后化学成分及其利尿作用研究［J］. 中国中医药信息杂志， 2020 ， 27 （ 4 ）： 59 - 65 .

曾春晖，杨柯，刘海燕，等 . 不同产地泽泻盐炙前后成分差异及利尿作用的研究［J］. 中国实验方剂学杂志， 2012 ， 18 （ 2 ）： 148 - 152 .

戴小欢，曲琰，贾天柱 . 不同炮制方法对泽泻中主要成分含量的影响［J］. 吉林中医药， 2009 ， 29 （ 4 ）： 330 - 331 .

曹柳，李青苗，方清茂，等 . 3种炮制方法对泽泻中4种三萜类成分的影响［J］. 中成药， 2016 ， 38 （ 9 ）： 1994 - 1998 .

魏玮，相芳，许诺，等 . 泽泻不同炮制品中7个化学成分的含量测定［J］. 中国药师， 2021 ， 24 （ 12 ）： 2284 - 2288 .

韩伟健，林晓彤，郭娜，等 . 泽泻盐制前后成分转化的1H NMR分析［J］. 波谱学杂志， 2016 ， 33 （ 1 ）： 117 - 124 .

谢雪，许枬，张宏达 . 泽泻盐炙过程中化学成分转化研究［C］// 中华中医药学会中药炮制分会 . 中华中医药学会中药炮制分会2011年学术年会论文集， 2011年卷.贵阳：中华中医药学会中药炮制分会， 2011 ： 392 - 398 .

朱玉岚，郑云枫，彭国平 . 单煎和共煎对泽泻生品及其不同炮制品中水煎出提取率的比较［J］. 福建中医药， 2006 ， 37 （ 2 ）： 39 - 40 .

张雯霞，冯敏，苗雨露，等 . 中药血清药物化学的应用现状概述［J］. 药物评价研究， 2019 ， 42 （ 7 ）： 1448 - 1453 .

张雅秋，渠弼，杨巧荷 . 中药血清药物化学研究进展［J］. 疾病监测与控制， 2019 ， 13 （ 2 ）： 148 - 151，157 .

DAI M ， LI S ， SHI Q ， et al . Changes in triterpenes in Alismatis Rhizoma after processing based on targeted metabolomics using UHPLC-QTOF-MS/MS ［J］. Molecules ， 2021 ， 27 （ 1 ）： 185 .

向茜，赵文燕，王蝉，等 . 基于UPLC-Q-TOF-MS的泽泻盐制前后萜类化学成分分析［J］. 中国实验方剂学杂志， 2022 ， 28 （ 19 ）： 154 - 161 .

YANG N ， DONG Y Q ， WU M F ， et al . Establishing a rapid classification and identification method for the major triterpenoids of Alisma orientale ［J］. Phytochem Anal ， 2020 ， 31 （ 3 ）： 384 - 394 .

LIU X ， LI S L ， ZHOU Y ， et al . Characterization of protostane triterpenoids in Alisma orientalis by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry ［J］. Rapid Commun Mass Spectrom ， 2010 ， 24 （ 11 ）： 1514 - 1522 .

张王宁，李爱平，李科，等 . 中药药效物质基础研究方法进展［J］. 中国药学杂志， 2018 ， 53 （ 10 ）： 761 - 764 .

策力木格，张小峰，苏都娜，等 . 血清药物化学在中药领域的应用现状［J］. 中国药房， 2017 ， 28 （ 7 ）： 978 - 981 .

JIA X K ， HUANG J F ， HUANG X Q ， et al . Alismatis Rhizoma triterpenes alleviate high-fat diet-induced insulin resistance in skeletal muscle of mice ［J］. Evid Based Complement Alternat Med ， 2021 ， 2021 ： 8857687 .

赵卓慧 . 泽泻醇B抗非酒精性脂肪性肝炎作用及机制研究［D］. 上海：中国科学院上海药物研究所， 2023 .

TAO Y ， JIANG E ， YAN J ， et al . A biochemometrics strategy for tracing diuretic components of crude and processed Alisma orientale based on quantitative determination and pharmacological evaluation ［J］. Biomed Chromatogr ， 2020 ， 34 （ 2 ）： e4744 .

向茜，赵文燕，王蝉，等 . 基于UHPLC-MS/MS探究不同炮制方法对泽泻化学成分的影响［J］. 时珍国医国药， 2022 ， 33 （ 9 ）： 2154 - 2157 .

郑云枫，朱玉岚，彭国平 . 泽泻炮制过程中23-乙酰泽泻醇B的转化［J］. 中草药， 2006 ， 37 （ 10 ）： 1479 - 1482 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

In Vitro and in vivo Component Identification of Danshenyin Based on UPLC-Q-TOF-MS/MS

Cinnamomi Ramulus-Alismatis Rhizoma in Treatment of External-contraction Diseases from Traditional Chinese Medicine and Modern Pharmacy： A Review

Analysis on Material Basis of Anti-COPD Effect of Euphorbia helioscopia Based on Serum Pharmacochemistry and Network Pharmacology

Related Author

ZHANG Sitong

HU Xianrun

LIU Wenkang

LEI Jinchun

CHENG Xuemei

WU Xiaojun

CHEN Wansheng

LI Manlin

Related Institution

Key Laboratory for Standardization of Chinese Medicines，Ministry of Education， Shanghai Key Laboratory for Compound Chinese Medicines，Institute of Chinese Materia Medica， Shanghai University of Traditional Chinese Medicine

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Information on Traditional Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

Shandong Academy of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰